Transforming the NSCLC Treatment Landscape with Antibody Drug Conjugates

News
Video

The transformative potential of antibody drug conjugates in NSCLC treatment is discussed, encompassing their design, bystander effect, biomarkers, and impact on the treatment landscape.

Related Videos
Experts on prostate cancer
Expert on lung cancer
Expert on lung cancer
Experts on lung cancer
Experts on lung cancer
Experts on lung cancer
Experts on lung cancer
Experts on lung cancer
Eytan M. Stein, MD, an expert on myelodysplastic syndrome